Administrative Supplements for the NCI P30 Cancer Center Support Grants for Multi-Channel Communication Campaigns for Improvements in Cancer Education and Outcomes (MICEO) in Underserved Populations
Administrative Supplements for the NCI P30 Cancer Center Support Grants for Multi-Channel Communication Campaigns for Improvements in Cancer Education and Outcomes (MICEO) in Underserved Populations
批准号:
10891776
负责人:
Eric R. Fearon
金额:
$20.0万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
未结题
起止时间:
1997-06-01 至 2028-05-31
关键词:
AddressAdministrative SupplementAdultAgeAwarenessBehavioralBreastCOVID-19 impactCOVID-19 pandemic effectsCancer CenterCancer Center Support GrantCatchment AreaCervicalCharacteristicsCollaborationsColorectalCommunicationCommunitiesCommunity HealthCountryEconomically Deprived PopulationEducation and OutreachEffectivenessEvaluationFederally Qualified Health CenterGeographyGoalsHealthHealth EducatorsHealth Service AreaIndividualInterventionLungMalignant NeoplasmsMedicalMichiganOutcomePatientsPerformancePopulationPositioning AttributePreventionPrimary CareReportingRisk FactorsScreening for cancerSocial MarketingTobacco useUnderserved PopulationUniversitiesVoiceWorkcancer educationcancer preventioncrowdsourcingdigitalevidence baseimplementation toolimprovedinnovationmedically underservedmortalityoutreachpandemic impactpatient engagementpeerperceived discriminationpopulation healthprogramsrecruitsatisfactionscreeningsocial health determinantssocial mediasocioeconomic disadvantagesuccesstool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
The goal of our project is to address common misperceptions about cancer prevention, increase rates of
cancer screenings (e.g. breast, cervical, colorectal, lung) and tobacco use intervention among otherwise
medically underserved adults age 30+ (Track 2). This project builds on our ongoing collaboration with the
Michigan Primary Care Association (our state FQHC network) and Packard Health (our local FQHC). Over the
past three years, we have worked together on the UM Rogel Cancer Center supported Catch Up on Cancer
Screening initiative to address the impact of COVID-19 pandemic on cancer screening. While we have had
initial success in these efforts, we have also identified critical needs to increase the effectiveness of population
health outreach, leverage and magnify the contributions of community health educators (CHEs), and identify
optimal strategies for patient engagement.
We propose to address these critical needs by 1) Developing a community-engaged personally tailored cancer
screening and prevention digital planning tool (CanPlan), 2) Promote CanPlan engagement through multi-
channel outreach (Direct-to-patient messaging, Proactive CHE outreach, Health center focused social
marketing, Local community focused social media, Peer-to-peer snowball recruitment). The tailored CanPlan
program will engage users to create a personally tailored cancer prevention action plan. Innovative features of
the CanPlan program include 1) Speaking in the voice of CHEs (through tailored video), 2) Incorporation of
local community and crowdsourced cancer screening and prevention messages, and 3) Recognizing and
responding to user reported everyday experience of discrimination, medical mistrust, and unmet social
determinants of health (SDOH) needs.
We will evaluate CanPlan implementation (e.g. engagement, engagement efficiency, user characteristics), and
patient-reported (understanding of cancer prevention key facts, behavioral activation, program satisfaction),
and utilization (e.g. cancer screening) outcomes. Evaluation will address CanPlan performance overall and
separately for each outreach channel. Upon completion of the proposed work, we will be in a strong position to
disseminate the CanPlan program and guide CanPlan promotion with stakeholders throughout the state and
potentially across the country.
期刊论文(888)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.neo.2020.12.001
发表时间:
2021-03
期刊:
Neoplasia (New York, N.Y.)
影响因子:
--
作者:
[Khera E, Cilliers C, Smith MD, Ganno ML, Lai KC, Keating TA, Kopp A, Nessler I, Abu-Yousif AO, Thurber GM]
通讯作者:
Thurber GM
DOI:
10.1111/biom.13580
发表时间:
2023-03
期刊:
BIOMETRICS
影响因子:
1.9
作者:
[Li, Mengbing, Park, Daniel E., Aziz, Maliha, Liu, Cindy M., Price, Lance B., Wu, Zhenke]
通讯作者:
Wu, Zhenke
DOI:
10.1111/add.15658
发表时间:
2022-03
期刊:
Addiction (Abingdon, England)
影响因子:
--
作者:
[Titus AR, Xie Y, Thrasher JF, Levy DT, Elliott MR, Patrick ME, Fleischer NL]
通讯作者:
Fleischer NL
DOI:
10.1007/s00520-022-07243-8
发表时间:
2022-10
期刊:
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
影响因子:
--
作者:
[]
通讯作者:
Rapid microsphere‐assisted peptide screening (MAPS) of promiscuous MHCII‐binding peptides in Zika virus envelope protein
寨卡病毒包膜蛋白中混杂的 MHCII 结合肽的快速微球辅助肽筛选 (MAPS)
DOI:
10.1002/aic.16697
发表时间:
2019
期刊:
AIChE Journal
影响因子:
3.7
作者:
[Smith, Mason R., Bugada, Luke F., Wen, Fei]
通讯作者:
Wen, Fei
共 520 条
Developmental Research Program
-
批准号:10554479
-
项目类别:
-
资助金额:$15.08万
-
财政年份:2023
-
负责人:Eric R. Fearon
-
依托单位:
Development of a Standardized Electronic Treatment Plan Builds for NCI-supported Clinical Trials Year 2
-
批准号:10440230
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2021
-
负责人:Eric R. Fearon
-
依托单位:
Development of a Standardized Electronic Treatment Plan Builds for NCI-supported Clinical Trials
-
批准号:10226720
-
项目类别:
-
资助金额:$29.46万
-
财政年份:2020
-
负责人:Eric R. Fearon
-
依托单位:
Development Research Program
-
批准号:7893341
-
项目类别:
-
资助金额:$8.12万
-
财政年份:2010
-
负责人:Eric R. Fearon
-
依托单位:
PROGRAM LEADERS
-
批准号:7304457
-
项目类别:
-
资助金额:$24.71万
-
财政年份:2006
-
负责人:Eric R. Fearon
-
依托单位:
ROLE OF BETA CATENIN/TCF PATHWAY DEFECTS IN CANCER
-
批准号:6085912
-
项目类别:
-
资助金额:$26.81万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
ROLE OF BETA CATENIN/TCF PATHWAY DEFECTS IN CANCER
-
批准号:6751499
-
项目类别:
-
资助金额:$26.72万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
The Role of Beta-catenin/Tcf Pathway Defects in Cancer
-
批准号:6985089
-
项目类别:
-
资助金额:$28.36万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
The Role of Beta-catenin/Tcf Pathway Defects in Cancer
-
批准号:7238864
-
项目类别:
-
资助金额:$26.73万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
ROLE OF BETA CATENIN/TCF PATHWAY DEFECTS IN CANCER
-
批准号:6633647
-
项目类别:
-
资助金额:$26.72万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
ROLE OF BETA CATENIN/TCF PATHWAY DEFECTS IN CANCER
-
批准号:6377771
-
项目类别:
-
资助金额:$26.73万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
The Role of Beta-catenin/Tcf Pathway Defects in Cancer
-
批准号:7125946
-
项目类别:
-
资助金额:$27.52万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
ROLE OF BETA CATENIN/TCF PATHWAY DEFECTS IN CANCER
-
批准号:6514406
-
项目类别:
-
资助金额:$26.72万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
The Role of Beta-catenin/Tcf Pathway Defects in Cancer
-
批准号:7420984
-
项目类别:
-
资助金额:$26.73万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
The Role of Beta-catenin/Tcf Pathway Defects in Cancer
-
批准号:7617644
-
项目类别:
-
资助金额:$26.73万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
COLON TUMOR PROJECT
-
批准号:6300693
-
项目类别:
-
资助金额:$10.37万
-
财政年份:2000
-
负责人:Eric R. Fearon
-
依托单位:
CDX2 Tumor Suppressor Pathway Defects in Colon Cancer
-
批准号:6919312
-
项目类别:
-
资助金额:$29.55万
-
财政年份:1999
-
负责人:Eric R. Fearon
-
依托单位:
CDX2 Tumor Suppressor Pathway Defects in Colon Cancer
-
批准号:8037373
-
项目类别:
-
资助金额:$27.13万
-
财政年份:1999
-
负责人:Eric R. Fearon
-
依托单位:
CDX2 Tumor Suppressor Pathway Defects in Colon Cancer
-
批准号:8700327
-
项目类别:
-
资助金额:$26.31万
-
财政年份:1999
-
负责人:Eric R. Fearon
-
依托单位:
CDX2 TUMOR SUPPRESSOR PATHWAY DEFECTS IN COLON CANCER
-
批准号:2881974
-
项目类别:
-
资助金额:$22.33万
-
财政年份:1999
-
负责人:Eric R. Fearon
-
依托单位:
海外基金